F9 rs104894807: Understanding This Rare Genetic Variant

What each genotype means

What is rs104894807?

The variant rs104894807 is a single nucleotide polymorphism (SNP) located on the X chromosome within the F9 gene. In genetic databases, this variant is often identified by its position on the X chromosome. Because it is located on the X chromosome, the way it affects an individual depends heavily on their biological sex. Males have only one X chromosome, meaning a single copy of a pathogenic variant can directly impact their health. Females have two X chromosomes, which often provides a protective effect; however, they can still be carriers or, in rarer instances, experience symptoms due to patterns of X-chromosome inactivation. This variant is considered rare in the general population, and its presence is typically investigated in the context of clinical evaluations for bleeding disorders.

The Role of the F9 Gene

The F9 gene is responsible for producing a protein called coagulation factor IX. This protein is a critical component of the blood coagulation cascade, a complex series of chemical reactions that allow blood to clot and stop bleeding after an injury. Factor IX circulates in the blood as an inactive zymogen until it is activated during the clotting process. Once active, it works with other clotting factors to convert factor X into its active form, which is essential for forming a stable fibrin clot. When the F9 gene contains a pathogenic variant, the body may produce insufficient amounts of factor IX or a dysfunctional version of the protein. This leads to a reduced ability to form clots, which is the underlying cause of hemophilia B, also known as Christmas disease.

Research and Clinical Associations

Research has established a strong link between variants in the F9 gene and hemophilia B. Hemophilia B is an X-linked recessive disorder, meaning that in males, a single pathogenic variant on the X chromosome is sufficient to cause the condition. The severity of the bleeding disorder often correlates with the specific type of mutation present in the F9 gene. While many variants are known to cause this condition, rs104894807 is specifically noted in clinical catalogs for its association with the disorder. Evidence for such variants is typically gathered through clinical case studies and family history analysis. Because hemophilia B can range from mild to severe, clinicians use genetic testing to identify the specific variant to better understand the potential clinical presentation and to guide appropriate management strategies for patients.

Population Frequency and Interpretation

The variant rs104894807 is classified as rare across global populations. In genetic studies, rare variants are those that appear at a very low frequency in the general population, often making them difficult to study without large-scale genomic databases. Because this variant is rare, it is not typically found in the general screening of healthy individuals. When it is identified, it is usually through targeted diagnostic testing for individuals who have already presented with symptoms of a bleeding disorder or who have a family history of hemophilia B. It is important to note that the presence of a rare variant does not automatically guarantee a specific clinical outcome, as other genetic and environmental factors can influence how a condition manifests in an individual.

What You Can Do With This Information

If you have received information about this variant, it is essential to understand that this is not a medical diagnosis. Genetic information is complex and should always be interpreted by a qualified healthcare professional, such as a genetic counselor or a hematologist. If you are concerned about bleeding symptoms or a family history of hemophilia, discuss these findings with your clinician. They can provide context based on your personal health history and determine if further diagnostic testing or specialized blood clotting studies are necessary. Never make changes to your medical care or treatment based on genetic reports without consulting your doctor. Genetic counseling is highly recommended for individuals who are carriers or who have been diagnosed with a bleeding disorder to understand the implications for themselves and their family members.

Frequently asked questions

Sources & further reading